Clinical Trials on Intraepithelial Prostatic Neoplasia in Finland
Total 2505 results
-
National Human Genome Research Institute (NHGRI)Completed
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
Thomas ZilliActive, not recruitingMalignant Neoplasm of Prostate | Local DiseaseNetherlands, Israel, Switzerland, Spain, Belgium, Finland, Portugal, Turkey
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
Brown UniversityTerminated
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Lidds ABCMX ResearchCompletedProstate CancerCanada, Finland, Lithuania
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Hoffmann-La RocheCompletedCervical Intraepithelial NeoplasiaBelgium, France, Spain, United States, Finland, Puerto Rico
-
University of OuluOulu University HospitalTerminatedUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic NeoplasmsFinland
-
University of OuluOulu University HospitalCompletedProstatic NeoplasmsFinland
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Brown UniversityKeitner/Family Therapy Research GrantCompletedBreast Cancer | Sexual Dysfunction | Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
-
Helsinki University Central HospitalKarolinska InstitutetRecruitingKidney Cancer | Urothelial Carcinoma | Prostate Carcinoma | Penile Cancer | Testicular CancerFinland
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
GlaxoSmithKlineCompletedNeoplasms, Prostate | Prostate Cancer After a Radical TreatmentSpain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
-
Tampere University HospitalTampere University; University of Eastern Finland; Finnish Cultural Foundation; Fimlab laboratoriesCompleted
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Inovio PharmaceuticalsCompletedCervical Dysplasia | Cervical High Grade Squamous Intraepithelial Lesion | HSILUnited States, Spain, Lithuania, Estonia, South Africa, Argentina, Brazil, Finland, Poland, Puerto Rico
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
US Oncology ResearchPfizerCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
-
Uppsala UniversityRecruitingProstate CancerNorway, Denmark, Finland, Sweden, United Kingdom
-
Blue Earth DiagnosticsParexelCompletedProstate CancerUnited States, Finland, Germany, Netherlands
-
Sven LöffelerOslo University Hospital; KlinbeforskRecruitingProstate CancerNorway, Denmark, Finland
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
Steba Biotech S.A.ICON plc; International Drug Development InstituteCompletedCancer of the ProstateNetherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Steba Biotech S.A.CompletedProstate CancerSpain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
-
Tampere University HospitalUniversity of Turku; University of Helsinki; Tampere University; Aalto UniversityRecruitingKidney Cancer | Breast Cancer | Metastatic Renal Cell Carcinoma | Ovarian Cancer | Prostate Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Ovarian Cancer | Metastatic Renal Cancer | Metastatic Kidney Cancer | Metastatic Ovary CancerFinland
-
University of HelsinkiCompletedBPH (Benign Prostatic Hyperplasia)Finland
-
University of HelsinkiUniversity of Turku; Oulu University Hospital; Tampere University; South Ostrobothnia...CompletedBPH (Benign Prostatic Hyperplasia)Finland
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel, Australia